Ajinomoto Builds Gene Therapy CDMO Capabilities Through $554m Forge Acquisition

 
• By Lisa Takagi
Forge will join Ajinomoto's CDMO business as wholly-owned subsidiary.
Forge will join Ajinomoto's CDMO business as wholly-owned subsidiary • Source: Shutterstock

More from Business

More from Scrip